Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Conjugate Vaccines
Revenue, means the sales value of Conjugate Vaccines
This report studies sales (consumption) of Conjugate Vaccines in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Astellas Pharma Inc
CSL Limited
Emergent BioSolutions, Inc
GlaxoSmithKline
Johnson & Johnson
MedImmune, LLC
Merck & Co
Pfizer
Sanofi Pasteur
Serum Institute
India Pvt. Ltd. (India)
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Pneumococcal
Influenza
HPV
Hepatitis
Rotavirus
DTP
Polio
MMR
Split by applications, this report focuses on sales, market share and growth rate of Conjugate Vaccines in each application, can be divided into
Pediatric
Adult
Application 3
United States Conjugate Vaccines Market Report 2021
1 Conjugate Vaccines Overview
1.1 Product Overview and Scope of Conjugate Vaccines
1.2 Classification of Conjugate Vaccines
1.2.1 Pneumococcal
1.2.2 Influenza
1.2.3 HPV
1.2.4 Hepatitis
1.2.5 Rotavirus
1.2.6 DTP
1.2.7 Polio
1.2.8 MMR
1.3 Applications of Conjugate Vaccines
1.3.1 Pediatric
1.3.2 Adult
1.3.3 Application 3
1.4 USA Market Size (Value and Volume) of Conjugate Vaccines (2011-2021)
1.4.1 USA Conjugate Vaccines Sales, Revenue and Price (2011-2021)
1.4.2 USA Conjugate Vaccines Sales and Growth Rate (2011-2021)
1.4.3 USA Conjugate Vaccines Revenue and Growth Rate (2011-2021)
2 USA Conjugate Vaccines Competition by Manufacturers
2.1 USA Conjugate Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Conjugate Vaccines Revenue and Share by Manufactures (2015 and 2016)
3 USA Conjugate Vaccines (Volume and Value) by Type
3.1 USA Conjugate Vaccines Sales and Market Share by Type (2011-2021)
3.2 USA Conjugate Vaccines Revenue and Market Share by Type (2011-2021)
4 USA Conjugate Vaccines (Volume) by Application
5 USA Conjugate Vaccines Manufacturers Analysis
5.1 Astellas Pharma Inc
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Conjugate Vaccines Product Type and Technology
5.1.2.1 Pneumococcal
5.1.2.2 Influenza
5.1.3 Conjugate Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)
5.2 CSL Limited
5.2.1 Company Basic Information,Manufacturing Base and Competitors
5.2.2 Pharmaceuticals Product Type and Technology
5.2.2.1 Pneumococcal
5.2.2.2 Influenza
5.2.3 Pharmaceuticals Sales, Revenue, Price of CSL Limited (2015 and 2016)
5.3 Emergent BioSolutions, Inc
5.3.1 Company Basic Information,Manufacturing Base and Competitors
5.3.2 Emergent BioSolutions, Inc Product Type and Technology
5.3.2.1 Pneumococcal
5.3.2.2 Influenza
5.3.3 Emergent BioSolutions, Inc Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)
5.4 GlaxoSmithKline
5.4.1 Company Basic Information,Manufacturing Base and Competitors
5.4.2 Sanofi Pasteur Product Type and Technology
5.4.2.1 Pneumococcal
5.4.2.2 Influenza
5.4.3 GlaxoSmithKline Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
5.5 Johnson & Johnson
5.5.1 Company Basic Information,Manufacturing Base and Competitors
5.5.2 Johnson & Johnson Product Type and Technology
5.5.2.1 Pneumococcal
5.5.2.2 Influenza
5.5.3 Johnson & Johnson Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
5.6 MedImmune, LLC
5.6.1 Company Basic Information,Manufacturing Base and Competitors
5.6.2 MedImmune, LLC Product Type and Technology
5.6.2.1 Pneumococcal
5.6.2.2 Influenza
5.6.3 MedImmune, LLC Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)
5.7 Merck & Co
5.7.1 Company Basic Information,Manufacturing Base and Competitors
5.7.2 Merck & Co Product Type and Technology
5.7.2.1 Pneumococcal
5.7.2.2 Influenza
5.7.3 Merck & Co Sales, Revenue, Price of Merck & Co (2015 and 2016)
5.8 Pfizer
5.8.1 Company Basic Information,Manufacturing Base and Competitors
5.8.2 Pfizer Product Type and Technology
5.8.2.1 Pneumococcal
5.8.2.2 Influenza
5.8.3 Pfizer Sales, Revenue, Price of Pfizer (2015 and 2016)
5.9 Sanofi Pasteur
5.9.1 Company Basic Information,Manufacturing Base and Competitors
5.9.2 Sanofi Pasteur Product Type and Technology
5.9.2.1 Pneumococcal
5.9.2.2 Influenza
5.9.3 Sanofi Pasteur Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)
5.10 Serum Institute
5.10.1 Company Basic Information,Manufacturing Base and Competitors
5.10.2 Serum Institute Product Type and Technology
5.10.2.1 Pneumococcal
5.10.2.2 Influenza
5.10.3 Serum Institute Sales, Revenue, Price of Serum Institute (2015 and 2016)
5.11 India Pvt. Ltd. (India)
6 Conjugate Vaccines Technology and Development Trend
6.1 Conjugate Vaccines Technology Analysis
6.2 Conjugate Vaccines Technology Development Trend
7 Research Findings and Conclusion
Figure Picture of Conjugate Vaccines
Table Classification of Conjugate Vaccines
Figure USA Sales Market Share of Conjugate Vaccines by Type in 2015
Figure Pneumococcal Picture
Figure Influenza Picture
Figure HPV Picture
Figure Hepatitis Picture
Figure Rotavirus Picture
Figure DTP Picture
Figure Polio Picture
Figure MMR Picture
Table Applications of Conjugate Vaccines
Figure USA Sales Market Share of Conjugate Vaccines by Application in 2015
Figure Pediatric Examples
Figure Adult Examples
Table USA Conjugate Vaccines Sales, Revenue and Price (2011-2021)
Figure USA Conjugate Vaccines Sales and Growth Rate (2011-2021)
Figure USA Conjugate Vaccines Revenue and Growth Rate (2011-2021)
Table USA Conjugate Vaccines Sales of Key Manufacturers (2015 and 2016)
Table USA Conjugate Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Conjugate Vaccines Sales Share by Manufacturers
Figure 2016 Conjugate Vaccines Sales Share by Manufacturers
Table USA Conjugate Vaccines Revenue by Manufacturers (2015 and 2016)
Table USA Conjugate Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Conjugate Vaccines Revenue Share by Manufacturers
Table 2016 USA Conjugate Vaccines Revenue Share by Manufacturers
Table USA Conjugate Vaccines Sales and Market Share by Type (2011-2021)
Table USA Conjugate Vaccines Sales Share by Type (2011-2021)
Figure Sales Market Share of Conjugate Vaccines by Type (2011-2021)
Figure USA Conjugate Vaccines Sales Growth Rate by Type (2011-2021)
Table USA Conjugate Vaccines Revenue and Market Share by Type (2011-2021)
Table USA Conjugate Vaccines Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Conjugate Vaccines by Type (2011-2021)
Figure USA Conjugate Vaccines Revenue Growth Rate by Type (2011-2021)
Table USA Conjugate Vaccines Sales and Market Share by Application (2011-2021)
Table USA Conjugate Vaccines Sales Share by Application (2011-2021)
Figure Sales Market Share of Conjugate Vaccines by Application (2011-2021)
Figure USA Conjugate Vaccines Sales Growth Rate by Application (2011-2021)
Table Astellas Pharma Inc Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)
Table CSL Limited Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of CSL Limited (2015 and 2016)
Table Emergent BioSolutions, Inc Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table MedImmune, LLC Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)
Table Merck & Co Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of Merck & Co (2015 and 2016)
Table Pfizer Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of Pfizer (2015 and 2016)
Table Sanofi Pasteur Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)
Table Serum Institute Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of Serum Institute (2015 and 2016)
Table India Pvt. Ltd. (India) Basic Information List
Table Conjugate Vaccines Sales, Revenue, Price of India Pvt. Ltd. (India) (2015 and 2016)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...